Early Access — free while we kick the tires
EdgarHawk

Enyedi Matthew

Group Managing Director

Officer
2 filings analyzed · 1 company · Latest 2026-02-27

Companies

Company Buys Sells Direction
LPL Financial Holdings Inc. LPLA 0 10 Net selling

Activity

February 2026
medium
Sell
2,109 shares
$675,192
Significance 5/10

LPL Financial Group MD Enyedi sells 2,109 shares totaling $675,191.74; stock down 24.7% from 52-week high

Enyedi Matthew, Group Managing Director at LPL Financial Holdings Inc., executed 5 separate sales totaling 2,109 shares for $675,191.74 on 2026-02-26 at a blended average price of $320.15, reducing his holdings by 13.0% from 16,230 to 14,121 shares. The timing coincides with a period of stock weakness: LPLA has declined 24.7% from its 52-week high of $399.00 and is down 18.1% over the past 30 days, trading at $300.38 versus the insider's transaction prices in the $318–$322 range. Historically at this ticker, Enyedi's prior sells have shown mixed outcomes—two of his three preceding sales at LPLA registered negative 90-day returns (well-timed), though one on 2024-02-26 saw positive returns (+8.1% at 90 days). The current sale's timing relative to the stock's recent selloff and elevated P/E of 37.74 against negative net income of -$29.5M in the latest quarter creates a divergence worth monitoring: the insider liquidated into a downturn, but without scheduled-trade disclosures, the motivation remains opaque.

February 2025
medium
Sell
5,154 shares
$1,903,527
Significance 5/10

Matthew Enyedi (Managing Director) sold 5,154 shares of LPLA at $369.33 on 2025-02-10; reduced stake 32.9% to 10.5K shares ($1.9M value).

Matthew Enyedi sold 5,154 shares at $369.33, reducing his stake by 32.9% just below the 52-week high of $371.05. At his same-ticker level, he has engaged in two prior sales at LPLA: one in 2024-02-26 (30d -0.2%, 90d +8.1%) and one in 2023-08-22 (30d +3.5%, 90d -2.5%). His same-ticker timing pattern shows only 1 of 2 prior sales were well-timed at the 90-day mark. This sale occurs amid strong recent momentum (30-day +12.3%, 90-day +16.8%) and elevated valuation (P/E 27.35), near the upper bound of the 52-week range. The transaction itself is factually observed; investors should note the reduction in executive position size coinciding with elevated near-term price action and above-average valuation multiples.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access